{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,23]],"date-time":"2026-09-23T15:13:32Z","timestamp":1790176412078,"version":"4.1.0"},"reference-count":54,"publisher":"Impact Journals, LLC","issue":"25","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Oncotarget"],"published-print":{"date-parts":[[2016,6,21]]},"DOI":"10.18632\/oncotarget.9400","type":"journal-article","created":{"date-parts":[[2016,5,22]],"date-time":"2016-05-22T07:21:38Z","timestamp":1463901698000},"page":"37636-37648","source":"Crossref","is-referenced-by-count":55,"title":["Genetic landscape of T- and NK-cell post-transplant lymphoproliferative disorders"],"prefix":"10.18632","volume":"7","author":[{"given":"Elizabeth","family":"Margolskee","sequence":"first","affiliation":[{"name":"Department of Pathology and Cell Biology, Columbia University Medical Center, New York, NY, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vaidehi","family":"Jobanputra","sequence":"additional","affiliation":[{"name":"Department of Pathology and Cell Biology, Columbia University Medical Center, New York, NY, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Preti","family":"Jain","sequence":"additional","affiliation":[{"name":"Department of Pathology and Cell Biology, Columbia University Medical Center, New York, NY, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jinli","family":"Chen","sequence":"additional","affiliation":[{"name":"Department of Pathology and Cell Biology, Columbia University Medical Center, New York, NY, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karthik","family":"Ganapathi","sequence":"additional","affiliation":[{"name":"Department of Pathology and Cell Biology, Columbia University Medical Center, New York, NY, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Odelia","family":"Nahum","sequence":"additional","affiliation":[{"name":"Department of Pathology and Cell Biology, Columbia University Medical Center, New York, NY, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brynn","family":"Levy","sequence":"additional","affiliation":[{"name":"Department of Pathology and Cell Biology, Columbia University Medical Center, New York, NY, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julie","family":"Morscio","sequence":"additional","affiliation":[{"name":"Department of Pathology, Translational Cell and Tissue Research Laboratory, UZ Leuven\/KU Leuven, Leuven, Belgium"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vundavalli","family":"Murty","sequence":"additional","affiliation":[{"name":"Department of Pathology and Cell Biology, Columbia University Medical Center, New York, NY, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas","family":"Tousseyn","sequence":"additional","affiliation":[{"name":"Department of Pathology, Translational Cell and Tissue Research Laboratory, UZ Leuven\/KU Leuven, Leuven, Belgium"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bachir","family":"Alobeid","sequence":"additional","affiliation":[{"name":"Department of Pathology and Cell Biology, Columbia University Medical Center, New York, NY, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mahesh","family":"Mansukhani","sequence":"additional","affiliation":[{"name":"Department of Pathology and Cell Biology, Columbia University Medical Center, New York, NY, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Govind","family":"Bhagat","sequence":"additional","affiliation":[{"name":"Department of Pathology and Cell Biology, Columbia University Medical Center, New York, NY, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"7892","published-online":{"date-parts":[[2016,5,27]]},"reference":[{"key":"1","first-page":"343","volume-title":"WHO Classification of Tumours of Haematopoietic and Lymphoid Tissues","author":"Vardiman","year":"2008"},{"key":"2","doi-asserted-by":"crossref","first-page":"887","DOI":"10.1309\/LYXN3RGF7D7KPYG0","article-title":"T-cell and NK-cell posttransplantation lymphoproliferative disorders","volume":"127","author":"Swerdlow","year":"2007","journal-title":"American journal of clinical pathology"},{"key":"3","doi-asserted-by":"crossref","first-page":"2190","DOI":"10.3109\/10428194.2013.775436","article-title":"Clinicopathological characteristics of posttransplant lymphoproliferative disorders of T-cell origin: single-center series of nine cases and meta-analysis of 147 reported cases","volume":"54","author":"Tousseyn","year":"2013","journal-title":"Leukemia & lymphoma"},{"key":"4","unstructured":"2008. WHO Classification of Tumours of Haematopoietic and Lymphoid Tissue. Lyon, IARC."},{"key":"5","doi-asserted-by":"crossref","first-page":"622","DOI":"10.1002\/humu.20495","article-title":"Impact of mutant p53 functional properties on TP53 mutation patterns and tumor phenotype: lessons from recent developments in the IARC TP53 database","volume":"28","author":"Olivier","year":"2007","journal-title":"Human mutation"},{"key":"6","doi-asserted-by":"publisher","first-page":"17764","DOI":"10.18632\/oncotarget.3776","article-title":"Genetic alterations of JAK\/STAT cascade and histone modification in extranodal NK\/T-cell lymphoma nasal type","volume":"6","author":"Ko","year":"2015","journal-title":"Oncotarget"},{"key":"7","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1038\/ng.2873","article-title":"Recurrent mutations in epigenetic regulators, RHOA and FYN kinase in peripheral T cell lymphomas","volume":"46","author":"Bhagat","year":"2014","journal-title":"Nature genetics"},{"key":"8","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1038\/bjc.2013.294","article-title":"Risk of lymphoma subtypes after solid organ transplantation in the United States","volume":"109","author":"Engels","year":"2013","journal-title":"British journal of cancer"},{"key":"9","doi-asserted-by":"crossref","first-page":"869","DOI":"10.1002\/1097-0215(200002)9999:9999<::AID-IJC1125>3.0.CO;2-N","article-title":"Lymphoproliferative disorders in renal transplant patients in Japan","volume":"91","author":"Aozasa","year":"2001","journal-title":"International journal of cancer"},{"key":"10","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1159\/000353783","article-title":"Angioimmunoblastic T cell lymphoma: an unusual presentation of posttransplant lymphoproliferative disorder in a pediatric patient","volume":"131","author":"Tan","year":"2014","journal-title":"Acta Haematologica"},{"key":"11","doi-asserted-by":"publisher","DOI":"10.1002\/jhbp.345","article-title":"Impact of human T-cell leukemia virus type 1 on living donor liver transplantation: a multi-center study in Japan","author":"Yamashita","year":"2016","journal-title":"Journal of hepato-biliary-pancreatic sciences"},{"key":"12","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1111\/j.1365-2141.2004.05212.x","article-title":"T-cell post-transplantation lymphoproliferative disorders after cardiac transplantation: a single institutional experience","volume":"127","author":"Alobeid","year":"2004","journal-title":"British Journal of Haematology"},{"key":"13","doi-asserted-by":"crossref","first-page":"992","DOI":"10.1093\/clinids\/21.4.992","article-title":"Development of human T-cell lymphotropic virus type I-associated adult T-cell leukemia\/lymphoma during immunosuppressive treatment following renal transplantation","volume":"21","author":"Breuer","year":"1995","journal-title":"Clinical infectious diseases"},{"key":"14","doi-asserted-by":"crossref","first-page":"1604","DOI":"10.1097\/01.pas.0000213317.59176.d2","article-title":"Impact of Epstein-Barr virus in monomorphic B-cell posttransplant lymphoproliferative disorders: a histogenetic study","volume":"30","author":"Swerdlow","year":"2006","journal-title":"The American journal of surgical pathology"},{"key":"15","doi-asserted-by":"crossref","first-page":"772","DOI":"10.1200\/JCO.2001.19.3.772","article-title":"Identification of prognostic factors in 61 patients with posttransplantation lymphoproliferative disorders","volume":"19","author":"Levy","year":"2001","journal-title":"Journal of clinical oncology"},{"key":"16","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1111\/j.1365-2141.2009.07956.x","article-title":"High resolution SNP array genomic profiling of peripheral T cell lymphomas, not otherwise specified, identifies a subgroup with chromosomal aberrations affecting the REL locus","volume":"148","author":"Kuppers","year":"2010","journal-title":"British journal of haematology"},{"key":"17","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1158\/1078-0432.CCR-08-1808","article-title":"Array comparative genomic hybridization analysis of PTCL-U reveals a distinct subgroup with genetic alterations similar to lymphoma-type adult T-cell leukemia\/lymphoma","volume":"15","author":"Seto","year":"2009","journal-title":"Clinical cancer research"},{"key":"18","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1038\/jid.2010.271","article-title":"Primary cutaneous CD30+ anaplastic large-cell lymphomas show a heterogeneous genomic profile: an oligonucleotide arrayCGH approach","volume":"131","author":"Barranco","year":"2011","journal-title":"The Journal of investigative dermatology"},{"key":"19","doi-asserted-by":"crossref","first-page":"1837","DOI":"10.1016\/S0002-9440(10)63742-X","article-title":"Genomic profiling of peripheral T-cell lymphoma, unspecified, and anaplastic large T-cell lymphoma delineates novel recurrent chromosomal alterations","volume":"164","author":"Ott","year":"2004","journal-title":"The American journal of pathology"},{"key":"20","doi-asserted-by":"crossref","first-page":"2683","DOI":"10.1182\/blood-2013-04-497933","article-title":"PRDM1\/BLIMP1 is commonly inactivated in anaplastic large T-cell lymphoma","volume":"122","author":"Bhagat","year":"2013","journal-title":"Blood"},{"key":"21","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1111\/j.1365-2141.2010.08125.x","article-title":"Single nucleotide polymorphism-arrays provide new insights in the pathogenesis of post-transplant diffuse large B-cell lymphoma","volume":"149","author":"Mian","year":"2010","journal-title":"British Journal of Haematology"},{"key":"22","doi-asserted-by":"crossref","first-page":"1901","DOI":"10.1182\/blood-2011-11-391748","article-title":"IDH2 mutations are frequent in angioimmunoblastic T-cell lymphoma","volume":"119","author":"Mak","year":"2012","journal-title":"Blood"},{"key":"23","doi-asserted-by":"crossref","first-page":"1741","DOI":"10.1182\/blood-2015-05-644591","article-title":"IDH2R172 mutations define a unique subgroup of patients with angioimmunoblastic T-cell lymphoma","volume":"126","author":"Li","year":"2015","journal-title":"Blood"},{"key":"24","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1038\/leu.2014.261","article-title":"Targeted mutational profiling of peripheral T-cell lymphoma not otherwise specified highlights new mechanisms in a heterogeneous pathogenesis","volume":"29","author":"Wendel","year":"2015","journal-title":"Leukemia"},{"key":"25","doi-asserted-by":"crossref","first-page":"1466","DOI":"10.1182\/blood-2012-02-408542","article-title":"Recurrent TET2 mutations in peripheral T-cell lymphomas correlate with TFH-like features and adverse clinical parameters","volume":"120","author":"Gaulard","year":"2012","journal-title":"Blood"},{"key":"26","doi-asserted-by":"crossref","first-page":"1293","DOI":"10.1182\/blood-2013-10-531509","article-title":"A targeted mutational landscape of angioimmunoblastic T-cell lymphoma","volume":"123","author":"Rodig","year":"2014","journal-title":"Blood"},{"key":"27","doi-asserted-by":"crossref","first-page":"442","DOI":"10.1016\/j.ccr.2014.02.010","article-title":"The R882H DNMT3A mutation associated with AML dominantly inhibits wild-type DNMT3A by blocking its ability to form active tetramers","volume":"25","author":"Ley","year":"2014","journal-title":"Cancer cell"},{"key":"28","doi-asserted-by":"publisher","DOI":"10.1038\/leu.2016.29","article-title":"DNMT3A mutant and Tet2 inactivation cooperate in the deregulation of DNA methylation control to induce lymphoid malignancies in mice","author":"Droin","year":"2016","journal-title":"Leukemia"},{"key":"29","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1056\/NEJMc1111708","article-title":"TET2 and DNMT3A mutations in human T-cell lymphoma","volume":"366","author":"Bernard","year":"2012","journal-title":"The New England journal of medicine"},{"key":"30","first-page":"4855","article-title":"Mutations in the p53 tumor suppressor gene: clues to cancer etiology and molecular pathogenesis","volume":"54","author":"Harris","year":"1994","journal-title":"Cancer research"},{"key":"31","first-page":"573","article-title":"Post-thymic T cell lymphomas frequently overexpress p53 protein but infrequently exhibit p53 gene mutations","volume":"144","author":"Knowles","year":"1994","journal-title":"The American journal of pathology"},{"key":"32","doi-asserted-by":"crossref","first-page":"1663","DOI":"10.1038\/sj.leu.2403840","article-title":"p53 gene mutations are uncommon but p53 is commonly expressed in anaplastic large-cell lymphoma","volume":"19","author":"Medeiros","year":"2005","journal-title":"Leukemia"},{"key":"33","doi-asserted-by":"crossref","first-page":"2280","DOI":"10.1182\/blood-2012-03-419937","article-title":"Genome-wide analysis reveals recurrent structural abnormalities of TP63 and other p53-related genes in peripheral T-cell lymphomas","volume":"120","author":"Milosevic","year":"2012","journal-title":"Blood"},{"key":"34","doi-asserted-by":"crossref","first-page":"2244","DOI":"10.1038\/leu.2014.200","article-title":"Frequent STAT5B mutations in gammadelta hepatosplenic T-cell lymphomas","volume":"28","author":"Raffeld","year":"2014","journal-title":"Leukemia"},{"key":"35","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1111\/bjh.13952","article-title":"Genes encoding members of the JAK-STAT pathway or epigenetic regulators are recurrently mutated in T-cell prolymphocytic leukaemia","volume":"173","author":"Siebert","year":"2016","journal-title":"British journal of haematology"},{"key":"36","doi-asserted-by":"crossref","first-page":"1905","DOI":"10.1056\/NEJMoa1114885","article-title":"Somatic STAT3 mutations in large granular lymphocytic leukemia","volume":"366","author":"Guinta","year":"2012","journal-title":"The New England journal of medicine"},{"key":"37","doi-asserted-by":"crossref","first-page":"516","DOI":"10.1016\/j.ccell.2015.03.006","article-title":"Convergent mutations and kinase fusions lead to oncogenic STAT3 activation in anaplastic large cell lymphoma","volume":"27","author":"Rinaldi","year":"2015","journal-title":"Cancer cell"},{"key":"38","doi-asserted-by":"crossref","first-page":"6025","DOI":"10.1038\/ncomms7025","article-title":"Activating mutations of STAT5B and STAT3 in lymphomas derived from gammadelta-T or NK cells","volume":"6","author":"Iqbal","year":"2015","journal-title":"Nature communications"},{"key":"39","doi-asserted-by":"crossref","first-page":"1589","DOI":"10.1182\/blood-2014-07-588970","article-title":"Receptor-type tyrosine-protein phosphatase kappa directly targets STAT3 activation for tumor suppression in nasal NK\/T-cell lymphoma","volume":"125","author":"Kwong","year":"2015","journal-title":"Blood"},{"key":"40","volume-title":"STAT3 Is Activated By EBV in T or NK Cells Leading to Development of EBV-T\/NK-Lymphoproliferative Disorders American Society of Hematology","author":"Ayako","year":"2014"},{"key":"41","doi-asserted-by":"crossref","first-page":"e166","DOI":"10.1371\/journal.ppat.0030166","article-title":"EBV latent membrane protein 1 activates Akt, NFkappaB, and Stat3 in B cell lymphomas","volume":"3","author":"Raab-Traub","year":"2007","journal-title":"PLoS pathogens"},{"key":"42","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1016\/j.bbrc.2008.11.053","article-title":"Epstein-Barr virus-derived EBNA2 regulates STAT3 activation","volume":"378","author":"Matsuda","year":"2009","journal-title":"Biochemical and biophysical research communications"},{"key":"43","doi-asserted-by":"crossref","first-page":"2292","DOI":"10.1111\/j.1600-6143.2009.02781.x","article-title":"Activation of the JAK\/STAT pathway in Epstein Barr virus+-associated posttransplant lymphoproliferative disease: role of interferon-gamma","volume":"9","author":"Martinez","year":"2009","journal-title":"American journal of transplantation"},{"key":"44","doi-asserted-by":"publisher","first-page":"1884","DOI":"10.18632\/oncotarget.2753","article-title":"Somatic MED12 mutations are associated with poor prognosis markers in chronic lymphocytic leukemia","volume":"6","author":"Vahteristo","year":"2015","journal-title":"Oncotarget"},{"key":"45","doi-asserted-by":"crossref","first-page":"654","DOI":"10.1016\/j.celrep.2014.03.047","article-title":"Uterine leiomyoma-linked MED12 mutations disrupt mediator-associated CDK activity","volume":"7","author":"Aaltonen","year":"2014","journal-title":"Cell reports"},{"key":"46","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1016\/j.immuni.2012.10.017","article-title":"CDK8 kinase phosphorylates transcription factor STAT1 to selectively regulate the interferon response","volume":"38","author":"Kovarik","year":"2013","journal-title":"Immunity"},{"key":"47","first-page":"380","article-title":"T-box transcription factors in cancer biology","volume":"1846","author":"Prince","year":"2014","journal-title":"Biochimica et biophysica acta"},{"key":"48","doi-asserted-by":"publisher","first-page":"17895","DOI":"10.18632\/oncotarget.4963","article-title":"Point mutations of the mTOR-RHEB pathway in renal cell carcinoma","volume":"6","author":"Sudarshan","year":"2015","journal-title":"Oncotarget"},{"key":"49","article-title":"4EBP1\/c-MYC\/PUMA and NFkappaB\/EGR1\/BIM pathways underlie cytotoxicity of mTOR dual inhibitors in malignant lymphoid cells","author":"Kaufmann","year":"2016","journal-title":"Blood"},{"key":"50","doi-asserted-by":"crossref","first-page":"712","DOI":"10.1093\/annonc\/mdv624","article-title":"A phase II study of everolimus (RAD001), an mTOR inhibitor plus CHOP for newly diagnosed peripheral T-cell lymphomas","volume":"27","author":"Kim","year":"2016","journal-title":"Annals of oncology"},{"key":"51","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1182\/blood-2015-02-629543","article-title":"The mTORC1 inhibitor everolimus has antitumor activity in vitro and produces tumor responses in patients with relapsed T-cell lymphoma","volume":"126","author":"Nowakowski","year":"2015","journal-title":"Blood"},{"key":"52","doi-asserted-by":"crossref","first-page":"2360","DOI":"10.1002\/ijc.24681","article-title":"The mechanisms underlying MMR deficiency in immunodeficiency-related non-Hodgkin lymphomas are different from those in other sporadic microsatellite instable neoplasms","volume":"125","author":"Barete","year":"2009","journal-title":"International journal of cancer"},{"key":"53","first-page":"79","article-title":"DNA damage, DNA repair and therapy-related cancer","author":"Thiopurines","year":"2006","journal-title":"British medical bulletin"},{"key":"54","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1016\/j.cancergen.2012.06.005","article-title":"Molecular inversion probes: a novel microarray technology and its application in cancer research","volume":"205","author":"Schiffman","year":"2012","journal-title":"Cancer genetics"}],"container-title":["Oncotarget"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.oncotarget.com\/lookup\/doi\/10.18632\/oncotarget.9400","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,5,12]],"date-time":"2020-05-12T13:03:34Z","timestamp":1589288614000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.oncotarget.com\/lookup\/doi\/10.18632\/oncotarget.9400"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,5,27]]},"references-count":54,"journal-issue":{"issue":"25","published-print":{"date-parts":[[2016,6,21]]}},"alternative-id":["9400","27203213"],"URL":"https:\/\/doi.org\/10.18632\/oncotarget.9400","relation":{},"ISSN":["1949-2553"],"issn-type":[{"value":"1949-2553","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,5,27]]}}}